AstraZeneca

News

AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

News

AstraZeneca and Daiichi Sankyo are eyeing regulatory filings for Enhertu in early breast cancer after a second phase 3 trial delivers.

News

AstraZeneca has become the latest pharma group to set up a direct-to-consumer sales channel in the US, covering Farxiga, Airsupra, and FluMist.

News

AstraZeneca has elevated its challenge to Medicare drug price negotiation powers to the Supreme Court of the US.

News

AstraZeneca has abandoned Fasenra development in COPD, but there is better news for the company with a new version of lupus drug Saphnelo.

News

AstraZeneca's PD-L1 inhibitor Imfinzi is the first drug therapy to be recommended for routine NHS use in limited-stage small cell lung cancer.